Cryo-Cell International

Cryo-Cell International

Cryo-Cell International was incorporated in 1992 and is headquartered in Oldsmar, Florida. The company emerged as an early entrant in the private cord blood banking industry, which became a regulated healthcare service under FDA oversight. Public records show the firm is controlled by the Mercado family, who have held board and executive roles since its founding. The company's business model centers on collecting umbilical cord blood and cord tissue from newborns, processing the stem cells, and storing them in cryogenic freezers. Clients pay an initial processing fee plus annual storage fees. Cryo-Cell holds FDA registration and accreditation from AABB (formerly American Association of Blood Banks). The firm has processed over 500,000 samples since inception, per the company's public filings. Cryo-Cell International is publicly traded on the OTC Markets under the symbol CCEL. As of 2024, the company reported annual revenue of approximately $30 million. The company operates a single storage facility in Oldsmar, Florida. No additional offices, philanthropic structures, or investment vehicles are disclosed. The key structural differentiator is that Cryo-Cell is a regulated biological storage facility, not a family office deploying capital. The company's mandate is operational: maintain sterile laboratories, manage cryogenic inventory, and comply with health regulatory standards. This positions the firm within healthcare services rather than asset management.